Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$31.32
-6.9%
$33.34
$28.34
$43.70
$16.07B0.64.39 million shs5.55 million shs
Insulet Co. stock logo
PODD
Insulet
$256.80
-4.6%
$270.56
$160.19
$289.46
$18.03B1.29709,684 shs1.10 million shs
STERIS plc stock logo
STE
STERIS
$221.25
-2.8%
$223.22
$197.82
$248.24
$21.74B0.92529,805 shs481,456 shs
Teleflex Incorporated stock logo
TFX
Teleflex
$138.00
-2.4%
$156.70
$128.55
$249.91
$6.40B1.21588,538 shs1.21 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-1.01%+0.91%-3.22%+15.14%-21.49%
Insulet Co. stock logo
PODD
Insulet
+2.26%+1.60%-1.29%+4.78%+64.05%
STERIS plc stock logo
STE
STERIS
+1.07%+2.19%+2.49%+12.57%+5.48%
Teleflex Incorporated stock logo
TFX
Teleflex
+0.72%+0.71%+4.30%-21.18%-35.06%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baxter International Inc. stock logo
BAX
Baxter International
4.4385 of 5 stars
2.25.01.74.01.91.72.5
Insulet Co. stock logo
PODD
Insulet
4.3646 of 5 stars
3.42.00.04.93.60.81.9
STERIS plc stock logo
STE
STERIS
4.3972 of 5 stars
2.43.04.23.83.11.71.3
Teleflex Incorporated stock logo
TFX
Teleflex
4.4922 of 5 stars
4.02.00.83.93.31.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.40
Hold$38.5623.10% Upside
Insulet Co. stock logo
PODD
Insulet
2.82
Moderate Buy$292.0613.73% Upside
STERIS plc stock logo
STE
STERIS
2.80
Moderate Buy$258.7516.95% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.09
Hold$182.6332.34% Upside

Current Analyst Ratings Breakdown

Latest TFX, STE, PODD, and BAX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
3/10/2025
Baxter International Inc. stock logo
BAX
Baxter International
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$39.00 ➝ $41.00
3/6/2025
Insulet Co. stock logo
PODD
Insulet
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$340.00
3/5/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$275.00 ➝ $191.00
3/4/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Underperform$235.00 ➝ $140.00
3/3/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$200.00 ➝ $149.00
2/28/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$214.00 ➝ $146.00
2/28/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform$220.00 ➝ $155.00
2/28/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
2/28/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral$255.00 ➝ $140.00
2/27/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Citizens Jmp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$10.64B1.51$4.86 per share6.45$16.69 per share1.88
Insulet Co. stock logo
PODD
Insulet
$2.07B8.71$3.38 per share75.96$10.49 per share24.48
STERIS plc stock logo
STE
STERIS
$5.40B4.03$14.07 per share15.73$65.43 per share3.38
Teleflex Incorporated stock logo
TFX
Teleflex
$3.05B2.10$14.84 per share9.30$94.49 per share1.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
-$649M-$1.28N/A11.470.93-5.05%16.67%4.93%5/1/2025 (Estimated)
Insulet Co. stock logo
PODD
Insulet
$206.30M$5.7944.3551.673.6220.19%24.46%8.33%5/8/2025 (Estimated)
STERIS plc stock logo
STE
STERIS
$378.24M$4.7146.9722.28N/A8.66%13.91%8.64%5/6/2025 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
$356.33M$1.4227.449.091.737.85%14.19%8.53%5/1/2025 (Estimated)

Latest TFX, STE, PODD, and BAX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025N/A
Baxter International Inc. stock logo
BAX
Baxter International
$0.48N/AN/AN/A$2.59 billionN/A
5/1/2025N/A
Teleflex Incorporated stock logo
TFX
Teleflex
$2.84N/AN/AN/A$699.37 millionN/A
2/27/2025Q4 2024
Teleflex Incorporated stock logo
TFX
Teleflex
$3.86$3.89+$0.03-$2.95$813.24 million$795.40 million
2/20/2025Q4 2024
Baxter International Inc. stock logo
BAX
Baxter International
$0.52$0.58+$0.06-$1.00$2.67 billion$2.75 billion
2/20/2025Q4 2024
Insulet Co. stock logo
PODD
Insulet
$1.00$1.15+$0.15$1.39$582.02 million$597.50 million
2/5/2025Q3 2025
STERIS plc stock logo
STE
STERIS
$2.33$2.32-$0.01$1.75$1.38 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$0.682.17%-1.40%N/A N/A
Insulet Co. stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
STERIS plc stock logo
STE
STERIS
$2.281.03%+9.51%48.41%20 Years
Teleflex Incorporated stock logo
TFX
Teleflex
$1.360.99%N/A95.77%N/A

Latest TFX, STE, PODD, and BAX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/11/2025
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.172.22%2/28/20252/28/20254/1/2025
1/28/2025
STERIS plc stock logo
STE
STERIS
quarterly$0.571.03%2/20/20252/20/20253/21/2025
2/27/2025
Teleflex Incorporated stock logo
TFX
Teleflex
quarterly$0.340.77%3/7/20253/7/20253/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.31
1.43
1.09
Insulet Co. stock logo
PODD
Insulet
1.21
3.68
2.80
STERIS plc stock logo
STE
STERIS
0.32
2.13
1.40
Teleflex Incorporated stock logo
TFX
Teleflex
0.37
2.42
1.39

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Insulet Co. stock logo
PODD
Insulet
N/A
STERIS plc stock logo
STE
STERIS
94.69%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.21%
Insulet Co. stock logo
PODD
Insulet
0.47%
STERIS plc stock logo
STE
STERIS
1.14%
Teleflex Incorporated stock logo
TFX
Teleflex
1.43%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
60,000512.92 million509.47 millionOptionable
Insulet Co. stock logo
PODD
Insulet
2,60070.23 million69.82 millionOptionable
STERIS plc stock logo
STE
STERIS
16,00098.25 million97.13 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
15,50046.37 million45.78 millionOptionable

Recent News About These Companies

Teleflex receives FDA 510(k) clearance of AC3 Range IABP
Teleflex wins FDA nod for intra-aortic balloon pump
RBC Capital Sticks to Their Hold Rating for Teleflex (TFX)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Baxter International stock logo

Baxter International NYSE:BAX

$31.32 -2.33 (-6.92%)
Closing price 03:59 PM Eastern
Extended Trading
$31.47 +0.15 (+0.48%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Insulet stock logo

Insulet NASDAQ:PODD

$256.80 -12.33 (-4.58%)
Closing price 04:00 PM Eastern
Extended Trading
$252.54 -4.26 (-1.66%)
As of 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

STERIS stock logo

STERIS NYSE:STE

$221.25 -6.32 (-2.78%)
Closing price 03:59 PM Eastern
Extended Trading
$221.03 -0.22 (-0.10%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Teleflex stock logo

Teleflex NYSE:TFX

$138.00 -3.38 (-2.39%)
Closing price 03:59 PM Eastern
Extended Trading
$137.52 -0.48 (-0.35%)
As of 05:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.